Work

Impact Of The 2022 Bronchodilator Responsiveness Criteria On Study Eligibility and Treatment Response To Inhaled Triple Therapy (BDP/FF/GB) In Moderate-To-Severe Asthma: A Post-Hoc Analysis Of TRIMARAN & TRIGGER.